|1.||Laakso, Markku: 1 article (01/2015)|
|2.||Jalanko, Mikko: 1 article (01/2015)|
|3.||Jääskeläinen, Pertti: 1 article (01/2015)|
|4.||Heliö, Tiina: 1 article (01/2015)|
|5.||Brites, Pedro: 1 article (01/2015)|
|6.||Laine, Mika: 1 article (01/2015)|
|7.||Orešič, Matej: 1 article (01/2015)|
|8.||Hyötyläinen, Tuulia: 1 article (01/2015)|
|9.||Jørgenrud, Benedicte: 1 article (01/2015)|
|10.||Malheiro, Ana R: 1 article (01/2015)|
06/11/2014 - "Many solid tumors contain an overabundance of phospholipid ethers relative to normal cells. "
01/01/1994 - "Tumor cell kinetics following long-term treatment with antineoplastic ether phospholipids."
11/01/1992 - "Ether phospholipids represent a new class of anti-cancer drugs which appear to exert their tumoricidal activity through a direct and indirect cytotoxic effect against tumor cells of different origins. "
05/01/1991 - "The availability of this new probe should permit the electron spin resonance spectroscopic approach to investigate ways by which anti-tumor ether phospholipids selectively destroy the tumor cells."
08/04/1995 - "Radioiodinated phospholipid ethers have shown the remarkable ability to selectively accumulate in a variety of animal tumors as well as in human tumor xenografts. "
|2.||Peroxisomal Disorders (Peroxisomal Disorder)
04/24/1998 - "Peroxisomes play an indispensible role in ether lipid biosynthesis as evidenced by the deficiency of ether phospholipids in fibroblasts and tissues from patients suffering from a number of peroxisomal disorders. "
01/10/1997 - "Peroxisomes are indispensable organelles for ether lipid biosynthesis in mammalian tissues, and the deficiency of these organelles in a number of peroxisomal disorders leads to deficiencies in ether phospholipids. "
07/01/1989 - "On the basis of these results, it is conceivable that these ether-phospholipids may be involved in allergic inflammation of human nasal airways."
04/01/1988 - "Increased vascular permeability of inflammation is accounted for by the formation/release of mediators, such as lipids derived from arachidonate (eicosanoids: prostaglandins, thromboxane A2 or leukotrienes) or from ether phospholipids (PAF-acether). "
|4.||Ehrlich Tumor Carcinoma
05/01/1992 - "We have characterized the cytostatic activity of two ether phospholipids, 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine and 1-hexadecylmercapto-2-methoxymethyl-rac-glycero-3-phosphocholine, on a human tumor cell line derived from a colon adenocarcinoma, HT29. "
01/01/1994 - "We have characterized the cytostatic activity of four ether phospholipids, the methoxy-substituted edelfosine (ET-18-OCH 3), the thio-derivative ilmofosine (BM 41.440), and two new aza-alkylphospholipids, BN 52205 and BN 52211, on a human tumor cell line derived from a colon adenocarcinoma, the HT29. "
|1.||Ethyl Ether (Ether)
|2.||Platelet Activating Factor
|9.||Thromboxane A2 (A2, Thromboxane)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)